TAM
WVE icon

Tiverton Asset Management’s Wave Life Sciences WVE Stock Holding History

Tiverton Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,475
Closed -$65K – 746
2019
Q2 		$65K Buy
2,475
+474
+24% +$13.3K ﹤0.01% 654
2019
Q1 		$78K Buy
2,001
+495
+33% +$20.1K ﹤0.01% 604
2018
Q4 		$63K Buy
+1,506
New +$67K ﹤0.01% 427
2018
Q3 		– Sell
-1,274
Closed -$49K – 427
2018
Q2 		$49K Buy
+1,274
New +$54.8K ﹤0.01% 393

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Tiverton Asset Management's WVE Position: Q3 2019 in Review

Tiverton Asset Management sold out of Wave Life Sciences (WVE) in Q3 2019, closing a stake of 2,475 shares — an estimated $65K sold.

Tiverton Asset Management first reported a position in WVE in Q2 2018 and held it in 4 quarters. The position peaked at $78K in Q1 2019. 88 funds tracked by Wall St. Rank hold WVE as of Q3 2019.

  • Tiverton Asset Management reported no remaining Wave Life Sciences position as of Q3 2019 after selling out during the quarter.
  • Tiverton Asset Management sold 2,475 Wave Life Sciences shares in Q3 2019, an estimated $65K.
  • Tiverton Asset Management first reported a position in Wave Life Sciences in Q2 2018 and held it in 4 quarters.
  • Tiverton Asset Management's Wave Life Sciences position peaked at $78K in Q1 2019.
  • 88 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.